Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Shaldon

Showing results (61-70 of 158) with videos related to

Pageof 16
Sort By:
Contributions to Nephrology|January 1, 1988
Dialysis-associated amyloidosis and beta-2-microglobulinJ Flöge, C Granolleras, S Shaldon, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1972
Access to blood sites for haemodialysis: the A-V fistulaS Shaldon, R Crockett, H F De Lisle Nichols
Clinical Nephrology|May 1, 1988
Does hemodialysis induce muscular release of myoglobin?J Floege, C Granolleras, S Shaldon, et al.
Nephron|January 1, 1988
Which membrane? Should beta-2-microglobulin decide on the choice of today's hemodialysis membrane?J Floege, C Granolleras, K M Koch, et al.
Contributions to Nephrology|January 1, 1992
Blood-dialyzer interactions: their role in long-term complications of hemodialysisG Lonnemann, J Floege, S Shaldon, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1981
Mixed hemofiltration (MHF): 18 months experience with ultrashort treatment timeS Shaldon, M C Beau, G Deschodt, et al.
Clinical Nephrology|July 2, 2003
Differences in the permeability of high-flux dialyzer membranes for bacterial pyrogensR Schindler, F Christ-Kohlrausch, U Frei, et al.
Artificial Organs|July 1, 1996
Bacterial challenge of NISSHO ultrafilter ETF 609: results of in vitro testingS Krautzig, G Lonnemann, S Shaldon, et al.
Journal of Clinical Microbiology|July 1, 1987
Ultrafiltration to reject human interleukin-1-inducing substances derived from bacterial culturesC A Dinarello, G Lonnemann, R Maxwell, et al.
Nephron|January 1, 1974
Anemia of the regular hemodialysis patient and its treatmentK M Koch, W D Patyna, S Shaldon, et al.
Pageof 16

Showing results (61-70 of 158) with videos related to

Sort By:
Pageof 16
Contributions to Nephrology|January 1, 1988
Dialysis-associated amyloidosis and beta-2-microglobulinJ Flöge, C Granolleras, S Shaldon, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1972
Access to blood sites for haemodialysis: the A-V fistulaS Shaldon, R Crockett, H F De Lisle Nichols
Clinical Nephrology|May 1, 1988
Does hemodialysis induce muscular release of myoglobin?J Floege, C Granolleras, S Shaldon, et al.
Nephron|January 1, 1988
Which membrane? Should beta-2-microglobulin decide on the choice of today's hemodialysis membrane?J Floege, C Granolleras, K M Koch, et al.
Contributions to Nephrology|January 1, 1992
Blood-dialyzer interactions: their role in long-term complications of hemodialysisG Lonnemann, J Floege, S Shaldon, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1981
Mixed hemofiltration (MHF): 18 months experience with ultrashort treatment timeS Shaldon, M C Beau, G Deschodt, et al.
Clinical Nephrology|July 2, 2003
Differences in the permeability of high-flux dialyzer membranes for bacterial pyrogensR Schindler, F Christ-Kohlrausch, U Frei, et al.
Artificial Organs|July 1, 1996
Bacterial challenge of NISSHO ultrafilter ETF 609: results of in vitro testingS Krautzig, G Lonnemann, S Shaldon, et al.
Journal of Clinical Microbiology|July 1, 1987
Ultrafiltration to reject human interleukin-1-inducing substances derived from bacterial culturesC A Dinarello, G Lonnemann, R Maxwell, et al.
Nephron|January 1, 1974
Anemia of the regular hemodialysis patient and its treatmentK M Koch, W D Patyna, S Shaldon, et al.
Pageof 16